PT-141 – COMPREHENSIVE RESEARCH PEPTIDE FOR MELANOCORTIN RECEPTOR AND NEUROENDOCRINE SIGNALING STUDIES

Scientific Overview of PT-141

PT-141, also known as Bremelanotide, is a synthetic heptapeptide analog of α-Melanocyte-Stimulating Hormone (α-MSH) designed to selectively activate melanocortin receptors (MC3R and MC4R). It is widely used in preclinical and mechanistic research examining neuroendocrine signaling and receptor-mediated pathways.

In in-vitro and in-vivo studies, PT-141 has been investigated for its influence on:

• Melanocortin Receptor Activation – analysis of MC3R and MC4R binding and downstream signaling mechanisms (Hadley et al., 1999)
• Central Nervous System Pathways – evaluation of peptide-mediated hypothalamic signaling and neuronal receptor modulation (Shadiack et al., 2002)
• Structure–Function Relationships – exploration of synthetic analog design and receptor selectivity within the melanocortin peptide family (Dorr et al., 2008)

PT-141 serves as an important model compound for research involving melanocortin receptor pharmacology, peptide–receptor interaction dynamics, and neuroendocrine regulation.